What is SynNutra?
SynNutra Equine operates at the intersection of veterinary science and performance nutrition, providing a suite of all-natural, veterinarian-formulated supplements. The company distinguishes itself by ensuring that all products are entirely free from prohibited substances, thereby maintaining strict compliance with international equestrian standards such as those set by the FEI. By addressing critical health domains including respiratory function, stress management, and athletic endurance, SynNutra serves a sophisticated demographic of horse owners and professional trainers who prioritize both performance and animal welfare. Their commitment to evidence-based formulation and customer satisfaction has established them as a trusted entity in the equine health sector.
How much funding has SynNutra raised?
SynNutra has raised a total of $60K across 1 funding round:
Debt
$60K
Debt (2021): $60K with participation from PPP
Key Investors in SynNutra
PPP
Public-Private Partnership
What's next for SynNutra?
With the successful closure of this funding round, SynNutra is entering a pivotal phase of growth. The strategic deployment of this capital will likely focus on expanding their distribution channels, enhancing research and development capabilities for new product lines, and strengthening their market presence in international equestrian hubs. As the company transitions through its current lifecycle stage, the focus will shift toward operational efficiency and scaling production to meet the rising demand for clean-label, high-performance equine supplements. Investors and stakeholders will be monitoring the firm's ability to maintain its rigorous quality standards while capturing a larger share of the global equine wellness market.
See full SynNutra company page
